Get a perfect gift for your loved ones. View Gift Offers
Erectile dysfunction is one of those conditions that men almost universally underreport to their doctors, to their partners, and often to themselves. In my 25 years of practice, I’ve seen what happens when men wait too long, when they chalk it up to stress or age and decide it’s not worth bringing up. The relationship strain, the loss of confidence, the quiet isolation of it. It affects more than just the bedroom.
When I started offering acoustic wave therapy at MENZ Clinic, it wasn’t because it was trending. It was because the mechanism made clinical sense to me as an internist. The majority of erectile dysfunction particularly the kind that develops gradually in men in their 40s, 50s, and 60s is vascular in origin. Penile blood vessels become less compliant over time, blood flow decreases, and the vascular infrastructure that produces an erection simply stops performing the way it should. A pill like Viagra addresses that in the moment. Acoustic wave therapy addresses the underlying vascular tissue.
Is the evidence base as robust as I’d like? Not yet this is still a developing field, and I’ll tell you that honestly. But the mechanism is sound, multiple randomized controlled trials show statistically significant improvement in erectile function scores, and the safety profile is excellent. For the right patient and part of my job is determining if you’re that patient MENZ Wave® is a legitimate, evidence-based option.
If you’re dealing with ED, come in. We’ll have an honest conversation about your situation and what’s actually going to help. That’s what medicine is supposed to be.
Dr. J, M.D., ABIM Board-Certified Physician | MENZ Clinic at Dr. J Anti-Aging Clinic
Let’s be direct about something most treatment pages skip over.
Erectile dysfunction isn’t just a physical issue. For most men, it’s tied up with self-worth, with relationships, with what it means to feel capable and present. It can create distance with a partner who may not know what’s happening. It can fuel anxiety that makes the problem worse. And the embarrassment of bringing it up even to a doctor keeps a lot of men suffering in silence for far longer than they need to.
Dr. J’s MENZ Clinic is a judgment-free environment. The men who come through these doors span every age, every background, every stage of the problem. Some arrive frustrated that pills aren’t working the way they used to. Some are dealing with the psychological weight of a condition they’ve never talked to anyone about. Some are simply looking for an option that doesn’t involve taking a pill 30 minutes before intimacy and hoping for the best.
Whatever brings you here, the conversation starts in private, stays in private, and is driven by clinical solutions not assumptions about you. That’s the MENZ standard.
Most erectile dysfunction in men over 40 is vasculogenic meaning the underlying problem is reduced blood flow due to compromised penile vasculature. Atherosclerosis, diabetes, hypertension, and the natural aging process all affect the small blood vessels and endothelial tissue of the penis over time.
MENZ Wave® delivers low-intensity acoustic energy precisely targeted pressure waves to penile tissue. This creates controlled microtrauma in the tissue that triggers a cascade of repair and growth responses. The clinical evidence points to three primary mechanisms:
Acoustic energy stimulates the expression of angiogenic growth factors including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). These signals trigger the formation of new blood vessels in treated tissue a process called neovascularization. More vessels means more blood flow capacity, which is foundational to erectile function.
Shockwave therapy has been shown to increase nitric oxide (NO) production in penile endothelial tissue. Nitric oxide is the primary vasodilatory signaling molecule that initiates erections it relaxes smooth muscle in penile arteries and corpora cavernosa, allowing blood to flow in. Increasing NO availability improves the vascular responsiveness that makes natural erections possible.
In patients with Peyronie’s disease, acoustic waves break down fibrous plaques the scar tissue deposits in the tunica albuginea that cause penile curvature and discomfort. Multiple systematic reviews have confirmed that LiSWT reduces plaque size and improves curvature in a meaningful proportion of patients, with pain reduction as a consistent secondary benefit.
The treatment is performed in the office. No anesthesia. No downtime. A handheld acoustic wave probe is applied to multiple zones of the penis and perineum over a 20–30 minute session. Most patients describe the sensation as mild pressure or a light tapping the energy levels used in LiSWT are specifically calibrated to be well below the threshold of pain. The standard protocol runs 6 sessions typically over 3–6 weeks, with results continuing to develop over the following months as vascular remodeling progresses.
WHAT A MENZ WAVE® SESSION LOOKS LIKE
Dr. J takes evidence transparency seriously. Below is an honest summary of the peer-reviewed literature on low-intensity shockwave therapy for ED and Peyronie’s disease including what the studies show, their limitations, and where the evidence is still developing.
A 2025 meta-analysis of 12 randomized controlled trials encompassing 882 men with vasculogenic ED found statistically significant improvements in the IIEF-EF (International Index of Erectile Function Erectile Function) domain score and Erection Hardness Score (EHS) following LiSWT compared to sham therapy. Participants achieving EHS ≥ 3 (suitable for intercourse) increased significantly in the treatment group. This represents the most comprehensive RCT-level analysis of LiSWT for ED currently available. PMID: Published online June 2025, Translational Andrology and Urology Honest note: Study specifically examined vasculogenic ED patients whose dysfunction is rooted in impaired penile blood flow. Results may be less applicable to patients with predominantly psychogenic, neurogenic, or hormonal ED. IIEF score improvements were statistically significant but individual results vary considerably.
Meta-Analysis of 12 RCTs: LiSWT for Vasculogenic ED (2025)
Lange et al. (2024) published long-term outcomes from a randomized sham-controlled trial at the University of Virginia (NCT04434352). LiSWT showed statistically significant improvement in erectile function at 1 and 2 years post-treatment compared to baseline. The study found a peak treatment effect at approximately 1 year, with benefits beginning to decline after 2 years providing important real-world data on treatment durability. 30 patients; Storz Medical device; twice-weekly treatment for 3 consecutive weeks. PMID: 39507860 Honest note: The 2-year peak and subsequent decline in efficacy is an important patient education point. LiSWT likely requires repeat treatment courses for sustained benefit analogous to maintenance protocols for other regenerative therapies. Dr. J discusses durability expectations with each patient during consultation.
Long-Term Durability: Randomized Sham-Controlled Trial (University of Virginia, 2024)
Hinojosa-Gonzalez et al. (Baylor College of Medicine), presented at the 2024 Sexual Medicine Society of North America (SMSNA) Fall Scientific Meeting, conducted a systematic review and meta-analysis of 16 studies with 907 patients. LiSWT alone was associated with a mean IIEF difference of +3.4 vs. control. PRP (P-Shot) alone showed +3.2. Crucially, the combination of LiSWT + PRP produced a mean IIEF improvement of +8.2 more than double either therapy used alone. This combination protocol is the clinical basis for MENZ Clinic's combined MENZ Wave® + MENZ Shot™ approach. PMID: Conference abstract, SMSNA 2024 (full publication pending) Honest note: This data was presented as a conference abstract and has not yet been published in a peer-reviewed journal. While the findings are compelling and consistent with the biological rationale for combination therapy, peer-reviewed publication and replication in independent studies are needed before this can be considered Level 1 evidence.
LiSWT and PRP: Combination Efficacy (SMSNA 2024)
Li, Xu & Man (BMC Urology, 2024) conducted a systematic review of 7 controlled trials with 475 patients evaluating LiSWT for Peyronie's disease. Meta-analysis found LiSWT significantly increased the proportion of men experiencing plaque size reduction (RD 0.27, 95% CI: 0.04–0.50, p=0.02) and improvement in penile curvature (RD 0.13, p=0.05) versus placebo. Pain reduction and IIEF improvement were additional documented benefits. PMID: 39375617 CONFLICTING EVIDENCE (Peyronie's): Shockwave therapy for Peyronie's disease is the subject of ongoing debate in the urology literature. While this meta-analysis shows statistically significant plaque reduction, the effect sizes are modest and some trials showed no difference vs. placebo. LiSWT is generally considered most beneficial for pain reduction in Peyronie's disease, with plaque reduction and curvature improvement being less consistent. It is not a replacement for collagenase injections (Xiaflex) or surgical correction in patients with significant curvature. Dr. J discusses realistic expectations for Peyronie's patients during consultation.
Study 4 LiSWT for Peyronie's Disease: Systematic Review & Meta-Analysis (BMC Urology, 2024)
Ergun et al. (Cochrane Database of Systematic Reviews, July 2025) conducted a comprehensive systematic review of LiSWT RCTs for ED covering literature through July 2024. Authors included researchers from the University of Minnesota, University of Michigan, and notably for local relevance Avant Concierge Urology in Winter Garden, Florida. This represents the highest-quality systematic review of LiSWT for ED available, and its inclusion of a Central Florida-based investigator reflects the treatment's established presence in this region. PMID: 40654049 Honest note: The Cochrane review is the most rigorous evidence synthesis available for this treatment. As with all systematic reviews in this field, the authors note that many included trials have methodological limitations (small sample sizes, variable treatment protocols, short follow-up periods). The overall conclusion is that LiSWT improves erectile function scores compared to sham, but more standardized, long-term RCTs are needed.
Study 5 Cochrane Systematic Review: LiSWT for ED (2025, Updated)
LiSWT for erectile dysfunction has a growing, legitimate evidence base supported by multiple RCTs and now a Cochrane systematic review. The research most consistently supports its use in men with mild-to-moderate vasculogenic ED. For Peyronie’s disease, evidence is promising but more variable pain reduction is the most consistent benefit. Dr. J presents realistic expectations based on your specific situation. Results are not guaranteed.
Randomized Controlled Trials
Included in 2025 meta-analysis confirming significant IIEF improvement vs. sham therapy
IIEF Score Improvement
Five-Star Reviews
No Medication Required
Improved Erectile Function: By stimulating neovascularisation and nitric oxide upregulation, MENZ Wave® addresses the vascular root cause of most ED in men over 40. Multiple RCTs confirm statistically significant improvements in IIEF-EF scores the validated clinical measure of erectile function.
Firmer, More Reliable Erections: Improved penile blood flow translates to stronger erections with greater consistency. Many patients report not just improved function, but improved confidence knowing the response is there when the moment calls for it.
Reduced Reliance on Medications: For some men, the goal isn’t to stop taking Viagra or Cialis entirely it’s to make them work better, or to reduce the dose needed. For others, the goal is to stop taking them altogether. Both outcomes have been documented in LiSWT clinical trials.
Treatment of Peyronie’s Disease: Acoustic wave therapy has published evidence for plaque size reduction, curvature improvement, and pain reduction in Peyronie’s disease. For men experiencing pain during erection or significant curvature, MENZ Wave® offers a non-surgical, physician-supervised option with an acceptable evidence base.
No Downtime: Each session takes 20–30 minutes. No anesthesia. No recovery period. Patients return to normal activity immediately. Most men schedule sessions during a lunch break or between work commitments.
Relationship & Confidence Impact: The effect of restored sexual function on a man’s relationship and self-image is something lab scores can’t fully capture. Patients routinely report improvements in confidence, intimacy, and relationship quality that extend well beyond the clinical metrics. That matters to Dr. J as much as the IIEF score.
LiSWT is best supported by evidence for a specific clinical profile. Part of Dr. J’s consultation process is determining whether you’re likely to benefit and being honest if another approach may serve you better.
Primarily psychogenic ED LiSWT targets vascular tissue. If your ED is primarily anxiety or psychological in origin, therapy, behavioral techniques, or low-dose daily PDE5 inhibitors may be more appropriate.
Severe neurogenic ED (post-radical prostatectomy) Evidence for LiSWT in this population is limited. Most systematic reviews exclude this population.
Active penile infection or skin condition treatment area must be clear for safe application.
Blood thinners / anticoagulants Discuss with Dr. J before scheduling; protocol may need adjustment.
Peyronie’s disease with curvature > 60° Surgical correction (penile plication or graft) may be more appropriate for severe deformity. Dr. J will refer appropriately.
Unrealistic expectations LiSWT improves erectile function; it does not guarantee spontaneous erections in all circumstances in all patients. Realistic goals discussion is part of every consultation.
If you’re not sure whether MENZ Wave® is right for you, the consultation answers that question. It’s confidential, it’s thorough, and it doesn’t cost anything to have the conversation.
What to expect from first contact to your final MENZ Wave® session no surprises.
Every lip filler appointment at Dr. J Anti-Aging Clinic is personalized to your anatomy and goals. Here is exactly what to expect from your first contact through your results timeline.
Non-invasive, drug-free, no downtime. Addresses vascular root cause. Restorative not just symptomatic. Published RCT evidence. Combines well with P-Shot.
Best evidence for vasculogenic ED. Results develop over weeks to months (not immediate). May require maintenance sessions. Not FDA-cleared for ED as standalone treatment.
Uses your own platelet-rich plasma. Evidence-based regenerative therapy. Combination with MENZ Wave® shows additive effect (IIEF +8.2).
Requires a single injection. Optimal as part of a combination protocol. Individual response varies.
Definitive solution 90%+ patient satisfaction in appropriate candidates. Permanent.
Irreversible surgery. Destroys natural erectile mechanism. Generally reserved for men who have failed all non-surgical options. Significant cost and recovery.
Addresses libido, energy, and secondary ED caused by hypogonadism. Necessary for men with confirmed low testosterone.
Testosterone replacement alone does not correct vasculogenic ED in most cases. Blood work required before initiation. Not appropriate for all patients.
Highly effective, well-studied, immediate effect. Appropriate for all ED types. Can be taken as-needed or daily.
Requires planning (30–60 min before). Side effects (headache, flushing, vision changes). Does not address the underlying vascular issue. Loss of spontaneity concerns. Does not work for all men.
No. Low-intensity acoustic wave therapy uses energy levels calibrated well below the threshold of pain. Most patients describe the sensation as mild pressure or a gentle tapping some describe it as barely noticeable. The treatment is performed without anesthesia. A small number of patients experience mild temporary sensitivity in the treatment area after the session, which typically resolves within a few hours.
The standard protocol is 6 sessions, typically delivered twice weekly for 3 weeks or once weekly for 6 weeks. Dr. J determines the specific schedule during your consultation based on your situation. Results continue to develop for several months after the final session as vascular remodeling progresses which means your best results may be 3–6 months after completing the course, not immediately afterward.
The honest answer is: yes, for the right patients and the evidence is getting stronger. Multiple randomized controlled trials and a 2025 Cochrane systematic review confirm that LiSWT produces statistically significant improvements in IIEF erectile function scores compared to sham treatment in men with vasculogenic ED. A 2025 meta-analysis of 12 RCTs involving 882 men showed significant improvements in both the IIEF-EF domain score and Erection Hardness Score. That said, this is not a 100% success rate treatment, and the evidence is strongest for mild to moderate vasculogenic ED. Dr. J discusses realistic expectations based on your specific clinical profile.
Yes with some important context. A 2024 systematic review and meta-analysis of 7 controlled trials (475 patients) found that LiSWT significantly increased plaque reduction and curvature improvement in Peyronie’s disease patients versus placebo. Pain reduction is the most consistent and well-documented benefit. Shockwave therapy is not a cure for
Yes with some important context. A 2024 systematic review and meta-analysis of 7 controlled trials (475 patients) found that LiSWT significantly increased plaque reduction and curvature improvement in Peyronie’s disease patients versus placebo. Pain reduction is the most consistent and well-documented benefit. Shockwave therapy is not a cure for Peyronie’s disease — it does not fully eliminate plaques in most patients, and it’s generally not recommended as the sole treatment for patients with severe curvature (greater than 60 degrees). For the right patient, it’s a viable non-surgical option that Dr. J evaluates on a case-by-case basis.
The evidence says yes, meaningfully so. A 2024 systematic review and meta-analysis presented at the Sexual Medicine Society of North America found that LiSWT alone produced an IIEF improvement of +3.4 compared to control. P-Shot (PRP) alone produced +3.2. The combination of LiSWT + PRP produced +8.2 — more than double either therapy alone. The biological rationale is sound: acoustic waves stimulate neovascularization and nitric oxide production, while PRP delivers concentrated growth factors that support tissue repair and regeneration. MENZ Clinic offers both as a combined MENZ Wave® + MENZ Shot™ protocol for patients who are appropriate candidates.
Based on long-term data from the University of Virginia randomized controlled trial (PMID: 39507860), results peak at approximately 12 months post-treatment and begin to decline after 2 years. This means MENZ Wave® is not a permanent, one-time fix for most patients it’s better understood as a restorative treatment that may benefit from maintenance sessions, similar to how other regenerative therapies are managed. Dr. J discusses the maintenance question during your follow-up consultation and will recommend additional sessions only if clinically appropriate.
Absolutely. MENZ Clinic operates with the same HIPAA protections as any physician’s practice. Your appointment, your consultation, and your treatment records are fully confidential. Dr. J’s staff is trained to handle men’s sexual health appointments with discretion. You will not be asked to explain your reason for visiting at the front desk. Your records are not shared without your consent
MENZ Clinic is Dr. J’s comprehensive men’s sexual health practice. MENZ Wave® is one component of a full treatment menu.
MENZ Shot™ (P-Shot® / Power PRP): Platelet-rich plasma injected into penile tissue to stimulate regeneration and improve vascular function. Combines with MENZ Wave® for additive IIEF improvement (+8.2 combined vs. +3.4 wave alone). The most evidence-supported combination for ED.
MENZ Tox Shot™ (Botox for ED): Botulinum toxin injection that relaxes smooth muscle in the penile vasculature, improving blood flow. A separate mechanism from acoustic wave therapy that can complement the MENZ Wave® protocol for selected patients.
MENZ Booster®(Testosterone / Hormone Optimization): For patients whose ED has a hormonal component, testosterone optimization addresses libido, energy, and secondary vascular ED. Blood work and clinical evaluation determine appropriateness. Often combined with acoustic wave therapy.
MENZ Grow® (Penile Enhancement): Non-surgical penile enlargement protocol using physician-administered fillers and/or fat transfer. Discussed separately from ED treatment; available to patients once sexual function concerns are addressed.
IV Therapy (IVPSA Orlando): Vitamin, B-complex, and NAD+ infusions that support energy, cardiovascular function, and overall metabolic health a complement to any ED treatment protocol.
Anti-Aging Treatments (Parent Clinic): Testosterone optimization, PRP, and regenerative therapies at the parent Dr. J Anti-Aging Clinic crossover naturally with MENZ Clinic’s sexual health focus particularly for men seeking comprehensive health optimization.